Habits of Leadership

The episode has genuine signal scattered across a lot of narrative padding - specific claims about AI IQ, existential risk statistics, and psychedelic research data are valuable, but long personal ayahuasca storytelling and basic AI explainers consume large portions of the runtime, diluting the useful-per-minute ratio considerably.

“at the end of 2024, the average IQ of AI was 114. So we already have, what I like to say, a new species on the planet that has a higher intelligence in general.”

“seven hours of ayahuasca, uh, equates to seven years psychotherapy, 15 minutes of bufo, the God molecule, five Meo DMT. It equates to 15 years of therapy.”

The synthesis of AI ethics, indigenous cosmology, and psychedelic-accelerated leadership development is a genuinely unusual framing, and the Aboriginal reframe of purpose from 'what is my path' to 'what is needed of me' is a crisp, counterintuitive idea; however, the underlying framework (trauma, healing, plant medicine, consciousness) follows a well-worn path among this category of thinker.

“What we think is what is needed of me, what is needed of me. And that was profound. It's like, oh, my Lord, here I am, still the Western thinking, oh, my path, my leadership, my this, my that, who am I?”

“my indigenous friends, when they look at what's happening with AI, they see it as the mineral sector. So the mineral Sector being, you know, when we talk about the elements, earth, air, fire, water and ether, spirit, this is the earth sector, the mineral sector, organizing itself”

Wallace has real practitioner credentials - a 1999 PhD on technology as a leadership substitute, founding a public AI company in 2013, chairing a VC fund, and Shark Tank visibility - but by episode time she has migrated firmly into professional speaker and book-promotion mode, with the conversation skewing toward personal spiritual journey rather than operational B2B insight.

“I was the first one in the world to write about technology as a substitute for human leaders”

“in 2013, I founded one of the world's first AI companies”

The episode contains a useful cluster of concrete data points - named survey sample sizes, percentage breakouts, specific drug protocols, named individuals who died, and exact regulatory references - but several key claims (the AI companion dialogues, the therapy-equivalence ratios, the IQ figure) are presented without sourcing or methodology, limiting their evidential weight.

“34% of the populations that we interviewed said that they do or have used psychedelics and another 7% said they haven't, but they're considering it and would like to. So let's go. 41% of the population are doing something or want to do something already with these medicines.”

“52% who use psychedelics reported long term improvements in their leadership and how they live. Uh, uh, 76% see increased creative idea generation. 63% saw a net positive change in their empathy at work”

The host is consistently deferential, self-deprecating, and apologetic about his own questions, frequently flagging them as 'banal' before asking them; he never challenges the unverifiable AI companion narratives, the unsourced therapy-equivalence claims, or the survey methodology, making this a warm promotional conversation rather than a probing interview.

“Um, I know this is just for someone like you, I'm sure this is going to sound like such a banal question, but can you help me understand what AI actually is and what's it doing?”

“Um, yeah, I'm just going to suggest, say to you like this book has got me thinking in a way that um, I haven't before”